[1] Chung JW, Park SH, Kim N, et al.Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging[J].J Am Heart Assoc,2014,3(4):e001119. [2] 从祥丰.中国11省队列人群脑卒中及其亚型发病状况及影响因素研究[D].北京:中国疾病预防控制中心, 2021. [3] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators.Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1211-1259. [4] Parmar JP, Rogers WJ, Mugler JP, et al.Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke[J].Circulation,2010,122(20):2031-2038. [5] Correction to: guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke, 2019, 50(12):e440-e441. [6] Sveinsson OA, Kjartansson O, Valdimarsson EM.Cerebral ischemia/infarction -epidemiology, causes and symptoms[J].Laeknabladid, 2014,100(5):271-279. [7] 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018, 51(9):666-682. [8] 王伊龙,赵性泉,刘新峰,等.高危非致残性缺血性脑血管事件诊疗指南[J].中国卒中杂志,2016,11(6):481-491. [9] 李世芳,王联军.高同型半胱氨酸与急性缺血性卒中神经功能损伤和动脉硬化形成的关系[J].海南医学, 2021,32(22):2887-2890. [10] 朱凌云.脑梗死患者神经功能损伤与危险因素分析[D].石河子:石河子大学,2008. [11] 刘文源, 李爱英, 孙晓晓, 等.血清前白蛋白和白蛋白与不同年龄段急性缺血性卒中患者短期转归的相关性[J].国际脑血管病杂志, 2017, 25(7):626-632. [12] 陈璐, 施建锋, 任杰.南京市秦淮区老年人脑卒中高危人群分布及危险因素分析[J].实用预防医学, 2021, 28(12):1526-1529. [13] 关静.TG/HDL-C比值在急性缺血性脑卒中疾病中的应用及相关性研究[J].国际医药卫生导报,2020,26(16):2435-2438. [14] Wakabayashi I, Daimon T.Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterol[J].Lipids Health Dis, 2019, 18(1):156. [15] 王莉,沈娟,陈从新,等.血液同型半胱氨酸水平与不同亚型脑卒中相关性的meta分析[J].中国老年学杂志, 2018, 38(9):2052-2055. [16] Teng YL,Chang YY,Liu JS,et al.Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients[J].J Neurol Sci, 2009, 284(1-2):36-39. [17] Omrani HQ, Shandiz EE, Qabai M, et al.Hyperhomocysteinemia, folateo and B12 vitamin in Iranian patients with acute ischemic stroke[J].ARYA Atheroscler, 2011, 7(3):97-101. [18] Wu X,Ding J,Ge A,et al.Acute phase homocysteine related to severity and outcome of atherothrombotic stroke[J].Eur J Intern Med, 2013, 24(4):362-367. [19] Markisic M, Pavlovic AM, Pavlovic DM.The impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever ischaemic stroke[J].Biomed Res Int, 2017, 2017(1):5489057. [20] Yao E, Tang Y, Xie M, et al.Elevated homocysteine level related to poor outcome after thrombolysis in acute ischemic stroke[J].Med Sci Monit, 2016, 22(1):3268-3273. [21] Graham IM, Daly LE, Redsum HM, et al.Plasma homocysteine as a risk factor for vascular disease.The European Concerted Action Project[J].JAMA, 1997, 277(22):1775-1781. [22] 朱芳梅.高血浆同型半胱氨酸对急性缺血性脑卒中预后的影响[J].卒中与神经疾病, 2010, 17(6):367-368. [23] 高腾,杨滨瑞,赵琳琳,等.缺血性脑卒中可预防性危险因素的研究进展[J].中国实验诊断学,2020,24(11):1920-1923. [24] Kim DE, Lee KB, Jang IM, et al.Associations of cigarette smoking with intracranial atherosclerosis in the patients with acute ischemic stroke[J].Clin Neurol Neurosurg, 2012, 114(9):1243-1247.